H ypercholesterolemia in animal models and humans is characterized by an endothelial dysfunction. This is manifested by a coronary vasoconstrictive response to the endothelium-dependent vasodilator acetylcholine in the absence of gross morphological findings of atherosclerosis.1-5 This abnormality may be due to reduced synthesis of endotheliumderived relaxing factor (EDRF), altered membrane receptor coupling mechanisms affecting EDRF synthesis, and impaired diffusion or augmented destruction of EDRF in the vascular wall.3,6-8 Alternatively, the vasoconstrictive response could be mediated by enhanced synthesis and/or release of an endothelium-derived contracting factor.8 '9 Endothelin is a 21-amino-acid endothelial-derived vasoconstrictor and mitogenic peptide that may function in a paracrine fashion to regulate vascular tone.10'11 In addition, endothelin is present in normal plasma, and its circulating concentrations are elevated in disease states that are characterized by abnormal endothelium-dependent relaxation to acetylcholine such as atherosclerosis and congestive heart failure,12-14 reflecting an imbalance between these two endothelium-derived factors. Indeed, studies have demonstrated that such pathophysiological concentrations of endothelin have functional importance in the control of regional and systemic vascular resistance. 15 The current study was designed to test the hypotheses that experimental hypercholesterolemia results in elevation of plasma and tissue endothelin immunoreactivity and that the abnormal acetylcholine-evoked coronary vasoconstriction in the hypercholesterolemic animals is associated with further elevation of plasma endothelin. We therefore determined concentrations and molecular forms of plasma endothelin immunoreactivity following a 2% cholesterol diet for 4 months in pigs and during intracoronary acetylcholine administration. Second, we assessed the presence of endothelin in the coronary vascular wall by using an immunohistochemistry. Methods
Fourteen 2-month-old male Yucatan minipigs weighing approximately 15 kg were randomly allocated to receive a normal diet (group 1, n=6) or a 2% cholesterol atherogenic diet including 20% tallow and 1% hog bile extract (group 2, n=8). Serum cholesterol and plasma endothelin concentrations were determined monthly. On the day of the experiment, the pigs were premedicated with 1 g ketamine IM, intubated, and mechanically ventilated with room air. Anesthesia was maintained with a titrated IV infusion (3 to 5 mL/min) of a mixture of 1 g ketamine, 10 eluted from the cartridges with 2 mL 90% methanol in 1% TFA and then dried and reconstituted for the radioimmunoassay. The recovery of the extraction procedure was 81% as determined by addition of synthetic endothelin to plasma. Interassay and intra-assay variations were 9% and 5%, respectively. The minimal level of detection is 0.5 pg per tube. The cross-reactivity of endothelin-2 and -3 and proendothelin in this assay was <5%, <3%, and <37%, respectively. For immunohistochemistry, the LAD was embedded in paraffin, and 6-,um-thick sections were cut and mounted on silanized slides as previously described. 12 The slides were incubated overnight at 60°C and deparaffinized with graded concentrations of xylene and ethanol. The slides were washed with 0.6% H202 in methanol for 20 minutes at room temperature to block endogenous peroxidase activity. Tissue was then incubated with 5% normal goat serum for 10 minutes (Dako Corp, Santa Barbara, Calif) at room temperature to reduce nonspecific background staining and then with rabbit polyclonal endothelin-1 antiserum diluted 1:1600 (Peninsula, Belmont, Calif) in humidified chambers for 24 hours at room temperature. Control slides were treated with dilute normal rabbit serum (Dako Corp). All treated slides were exposed for 30 minutes to goat anti-rabbit antiserum diluted 1:100 (Tago Inc, Burlingame, Calif) to which peroxidase had been covalently linked. Peroxidase activity was visualized with 3-amino-9-ethylcabazole (Sigma Chemical, St Louis, Mo) dissolved in dimethylformamide and sodium acetate. The sections were counterstained with hematoxylin, mounted, and reviewed with an Olympus microscope.
Gel permeation chromatography (GPC) was used to characterize the molecular form of endothelin in plasma. Endothelin was characterized from nonextracted plasma by a P-6 (Bio-Rad Laboratories, Richmond, Calif) gel filtration column (1 x 13 cm). Five hundred microliters of plasma was applied to the column and eluted with 0.5 mol/L acetic acid buffer.
Fractions of 0.5 mL were collected and dried by Speedvac. The concentrations of endothelin were determined by radioimmunoassay as described above. The P-6 column was calibrated with synthetic 1'I endothelin-1 and 1'I big endothelin (Peninsula). Big endothelin was eluted from fractions 5 to 9 (peak fraction at 7), and endothelin-1 was eluted from fraction 7 to 17 (peak fraction at 11). Total endothelin recovery was determined by adding the concentrations of each fraction (5 through 17) after the subtraction of background (5 pg (Fig 3) in the LAD demonstrated that endothelin was present in the endothelial cells as well as in the subendothelial myointimal cells and/or macrophages in coronary arteries taken from the hypercholesterolemic pigs. There was no endothelin immunoreactivity in the LADs from the pigs that were on a normal diet. Sections of coronary arteries from both groups treated with nonimmune rabbit serum showed an absence of immunoreactivity.
GPC studies revealed that the dominant molecular form of endothelin in both groups at baseline and after acetylcholine administration is endothelin-1 (Fig 4) . Discussion This study establishes that hypercholesterolemia induced by a 2% cholesterol diet for 4 months in pigs elevates plasma endothelin concentration and enhances coronary artery tissue endothelin immunoreactivity. Second, the endothelium-dependent vasodilator acetylcholine further increased plasma endothelin in hypercholesterolemia in association with coronary vasoconstriction. The predominant molecular form of endothelin in hypercholesterolemia is the biologically active endothelin-1.
We have previously reported the elevation of circulating endothelin in humans with advanced atherosclerosis 4 . Plot of a representative gel filtration chromatogram of plasma from a pig on high cholesterol diet. This representative chromatogram demonstrates that the predominant endothelin molecular form in the plasma from both groups before and during acetylcholine administration is endothelin-1. A similar chromatographic pattern was obtained from both groups at baseline and during acetylcholine administration. choline may be an early marker of atherosclerosis in the absence of angiographically demonstrable lesions. Based on the current findings, we conclude that plasma endothelin concentrations may also serve as a marker for endothelial dysfunction and early atherosclerosis.
Previous in vitro studies have demonstrated that hypercholesterolemia and oxidized low-density lipoprotein interfere with endothelium-dependent relaxation by attenuating EDRF activity18 and/or stimulating the expression of endothelin mRNA as well as the release of endothelin.19 Our current study is in accordance with these previous observations and suggest that the functional balance between endothelium-mediated vasodilation and vasoconstriction may be disrupted in the early stage of atherosclerosis. This may lead to attenuated release of endothelium-derived vasodilator and antimitogenic factor EDRF and augmented release of the vasoconstrictor and mitogenic peptide endothelin.9 In response to intracoronary acetylcholine, a further and brief increase in circulating endothelin concentration occurred. This increase in circulating endothelin may suggest a regulated mechanism that releases endothelin from secretory granules. The elevation of plasma endothelin concentrations correlated with the degree of coronary vasoconstriction, implying an association between these two observations.
The The presence of endothelin-like immunoreactivity in the vascular wall of the coronary artery of the hypercholesterolemic pigs could reflect an internalization of endothelin produced in endothelial cells or the active production of endothelin.30,31 The specific cell types that are positive for endothelin-like immunoreactivity could include vascular smooth muscle cells, macrophages, and fibroblasts. The localization of endothelin in the hypercholesterolemic vascular wall may reflect the site of atheroma progression and neointimal proliferation32 since endothelin is a mitogenic peptide. One may thus speculate that endothelin participates as a mitogen or as a comitogen in the presence of other growth factor release by macrophages in the atherogenic process to stimulate smooth muscle cell proliferation.
In summary, the present study demonstrates that a high cholesterol diet for 4 months in pigs results in elevated plasma endothelin concentrations and enhances endothelin immunoreactivity in the coronary vascular wall. In response to intracoronary administration of acetylcholine, further elevation of plasma endothelin concentrations occurs that correlates with the degree of coronary vasoconstriction. Moreover, the current study demonstrates that this plasma increase is that of the molecular biologically active endothelin-1. This study supports a role for endothelin as an early participant and/or a marker for the endothelial dysfunction in hypercholesterolemia and in the atherogenic the National Heart Foundation of New Zealand. J.C.B.Jr. is an Established Investigator of the American Heart Association.
